Related Experiment Video
Updated: Jul 12, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Lung inflammation and pulmonary function in infants with meconium aspiration syndrome
Rowena G Cayabyab1, Kenny Kwong, Craig Jones
1Division of Neonatal Medicine, Department of Pediatrics, LAC+USC Medical Center, University of Southern California, Keck School of Medicine, Los Angeles, California, 90033, USA. cayabyab@usc.edu
Objective:
To evaluate the relationship between inflammation and pulmonary function, we quantified changes in inflammatory cellular profile, pro-inflammatory cytokines, and pulmonary function in intubated neonates with meconium aspiration syndrome (MAS).
Methods:
Sixteen term infants were studied. Tracheal aspirate fluids, obtained within the first 6, 24, 48, and 96 hr of life were used for measurements of: (1) cellular profile changes; (2) mRNA and protein levels for pro-inflammatory cytokines, IL-1beta, IL-6, IL-8, and TNF-alpha, using RT-PCR and ELISA. Using the same time points as above, we determined mean airway pressure, oxygenation index (OI), alveolar-arterial oxygen gradient, and arterial/alveolar oxygen ratio. Baseline tidal volume and pulmonary compliance were obtained.
Results:
Birth weight was 3,820 +/- 656 g, gestational age 39.8 +/- 1.4 weeks. Mean airway pressure and OI significantly decreased from the first 6-96 hr of age (P = 0.01, P = 0.027). Cell counts were elevated in the first 6 hr compared to 96 hr (17.4 x 10(6)/ml vs. 1.5 x 10(6)/ml, P < 0.05). Pro-inflammatory cytokines decreased from the first 6-96 hr: IL-1beta (187 vs. 37 pg/ml, P < 0.05); IL-6 (3,469 vs. 150 pg/ml, P < 0.05); IL-8 (16,230 vs. 6,334 pg/ml, P = 0.01).
Conclusions:
MAS is associated with an inflammatory response characterized by the presence of elevated cell count and pro-inflammatory cytokines which significantly decreased by 96 hr of life. This decrease in lung inflammation has a positive correlation with corresponding decreases in mean airway pressure and oxygenation index, two parameters associated with improved pulmonary function.
Insights
Meconium aspiration syndrome (MAS) involves inflammation with high cell counts and cytokines. Lung inflammation improves pulmonary function by 96 hours, indicated by reduced airway pressure and oxygenation index.
Area of Science:
- Neonatal Medicine
- Respiratory Physiology
- Immunology
Background:
- Meconium aspiration syndrome (MAS) is a significant cause of respiratory distress in term neonates.
- Inflammation plays a critical role in the pathophysiology of MAS, impacting lung function.
Purpose of the Study:
- To investigate the relationship between inflammatory markers and pulmonary function in neonates with MAS.
- To quantify changes in cellular profiles, pro-inflammatory cytokines, and respiratory parameters over time.
Main Methods:
- Studied 16 term infants with MAS.
- Analyzed tracheal aspirates for cellular counts and pro-inflammatory cytokines (IL-1beta, IL-6, IL-8, TNF-alpha) via RT-PCR and ELISA at 6, 24, 48, and 96 hours of life.
- Monitored pulmonary function parameters including mean airway pressure, oxygenation index (OI), and alveolar-arterial oxygen gradient.
Main Results:
- Pulmonary function improved, with significant decreases in mean airway pressure (P=0.01) and OI (P=0.027) from 6 to 96 hours.
- Tracheal aspirate cell counts decreased significantly from 17.4 x 10(6)/ml at 6 hours to 1.5 x 10(6)/ml at 96 hours (P<0.05).
- Pro-inflammatory cytokine levels (IL-1beta, IL-6, IL-8) also showed significant reductions by 96 hours (P<0.05).
Conclusions:
- MAS is characterized by an initial inflammatory response with elevated cellular and cytokine levels.
- A decrease in lung inflammation by 96 hours correlates with improved pulmonary function, evidenced by reduced mean airway pressure and OI.
- These findings highlight the dynamic inflammatory process in MAS and its impact on respiratory outcomes.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pulmonary Cycle: Exhalation
Breathing

